Home NDC 69448-016 HERCESSI
Product NDC 69448-016
11-digit product format 694480016
Labeler code 69448
Product ID 69448-016_893932c5-c667-4ed0-a2bd-a62cc5800b14
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Trastuzumab-strf
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Accord BioPharma Inc.
Application BLA761346
Marketing category BLA
Marketing start 2025-01-01
Substance TRASTUZUMAB-STRF
Active strength 420 mg/20mL
Pharmacologic classes HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base HERCESSI
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TRASTUZUMAB-STRF 420 mg/20mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination P188ANX8CK Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2700718 Internal RxNorm lookup 2700724 Internal RxNorm lookup 2700727 Internal RxNorm lookup 2700731 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69448-016-11 HERCESSI 20 mL in 1 VIAL, MULTI-DOSE INJECTION, POWDER, LYOPHILIZED, 20 4 69448-016-11 HERCESSI 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69448-016 HERCESSI (TRASTUZUMAB-STRF) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD BIOPHARMA INC.] 4 Current NDC, 2 package rows 20250323_285d2142-5bfa-401c-9246-7de21c4451af.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join HERCESSI TRASTUZUMAB-STRF Accord BioPharma Inc. 285d2142-5bfa-401c-9246-7de21c4451af 2026-10-02 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761346 ndc (product): 69448-016
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761346 Hercessi trastuzumab-strf 351(k) Biosimilar Rx 2026-10-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 69448-016-11 69448001611 1 VIAL, MULTI-DOSE in 1 CARTON (69448-016-11) / 20 mL in 1 VIAL, MULTI-DOSE 2025-01-01 No No Current